Trade Ideas April 5, 2026

Yara: Positioned to Profit from a Urea Price Shock

A long trade on cyclically cheap fertilizer exposure as urea tightness meets a low PE and manageable balance sheet

By Hana Yamamoto YARIY
Yara: Positioned to Profit from a Urea Price Shock
YARIY

Yara International (YARIY) looks inexpensive at a $14.8B market cap and a PE of ~10.8. A persistent upswing in urea and ammonia markets, plus project optionality in clean ammonia, creates asymmetric upside. This trade targets a re-rating into the $36 area over the next 180 trading days while limiting downside with a $25.50 stop.

Key Points

  • Yara offers direct exposure to rising urea/ammonia margins with a current market cap of $14.78B and PE ~10.8.
  • Trade plan: enter at $29.01, stop $25.50, target $36.00 over a long term (180 trading days) horizon.
  • Catalysts include spot fertilizer price moves, utilization improvements at export plants, and progress on clean ammonia projects.
  • Major risks: commodity reversals, operational outages, capex and execution risk, and energy price shocks.

Hook & thesis

Fertilizer markets are cyclic, but the next cycle looks different: supply-side tightness in urea/ammonia — driven by feedstock constraints and decarbonization-related capex delays — is creating a price shock the market has underappreciated. Yara International (YARIY), one of the world's largest fertilizer producers, sits squarely in the path of that shock. With a $14.78 billion market cap, a trailing PE of 10.77 and a 52-week trading range of $13.50 to $29.45, Yara is priced like a company that won't benefit much from higher fertilizer prices. I disagree.

Why the market should care

Yara is an industrial fertilizer and ammonia player with global scale: production and sales across Europe, the Americas, Africa and Asia, plus dedicated segments for Clean Ammonia and Industrial Solutions. Urea and ammonia are central to Yara's profit cycle. Higher urea prices feed directly into operating leverage for plants that are running and contracted on merchant markets. At a current price of $29.01, Yara is trading near its 52-week high, but the company still looks cheap on fundamentals (PE 10.8, PB 1.69) relative to the upside in a commodity cycle.

Concrete fundamentals to anchor the case

  • Market cap: $14,779,202,520.
  • Shares outstanding: 509,452,000; float: 344,210,000.
  • Valuation: PE = 10.77; PB = 1.69; trailing dividend yield ~0.59%.
  • Trading technicals: 10-day SMA $27.70, 20-day SMA $27.69, 50-day SMA $25.39; RSI ~63 and a slightly positive MACD histogram, suggesting bullish momentum without excessive overbought readings.

Those numbers tell two things. First, scale and balance-sheet size are meaningful: nearly half a billion shares and a $14.8B cap means this is an institutional-sized story. Second, valuation is not demanding — a mid-teens operating swing in margins from higher urea/ammonia prices could produce outsized earnings upgrades compared with the current market multiple.

Why a urea price shock is plausible

Three structural factors push the case: (1) global ammonia production is capital intensive and new low-emission projects are large and lumpy, meaning supply additions are lumpy and can be delayed; (2) feedstock natural gas and spot hydrogen economics create regional bottlenecks that lift urea spreads in importing regions; (3) policy and corporate decarbonization put a premium on cleaner ammonia, creating near-term constraints on merchant merchant-output from legacy plants that face retrofitting or closure decisions.

Yara is actively engaged in clean ammonia projects with partners and has a $1.4 billion revolving credit facility refinanced in 03/20/2025, which provides liquidity to manage project timing. It is also in commercial discussions with major industry players on low-emission projects - a development that could create long-term strategic optionality and shorten the pathway from higher spot prices to sustained margin improvements.

Valuation framing

At a $14.78B market cap and a PE of 10.8, Yara is priced like a company with modest cyclic upside. That’s conservative for a producer where incremental urea price upside largely drops to the bottom line. Consider that the stock traded as low as $13.50 last year and as high as $29.45 this March; the market is already giving some credit for recovery. But the current multiple leaves room for re-rating if earnings inflect materially higher because fertilizer cycles historically translate quickly into margin and free cash flow swings — and investors tend to re-rate commodity-exposed names when the cycle turns.

Qualitatively, if urea prices rise and average utilization improves across Yara's export-oriented plants (Porsgrunn, Sluiskil and others), free cash flow could expand meaningfully. Given the company’s relatively low dividend yield and sizeable capex optionality into clean ammonia, excess cash would likely go to strengthening the balance sheet and potentially buybacks or special dividends over time — actions which would materially compress the share count and lift per-share metrics.

Catalysts (what to watch)

  • Urea and ammonia spot price moves: sustained rallies would flow directly to margins; watch regional spreads and import parity in major consuming markets.
  • Commercial decisions and announcements on the company's clean ammonia projects and partnerships - these are strategic and can de-risk future earnings (press coverage 12/08/2025 referenced joint projects with major partners).
  • Operational updates from Yara’s large plants (Porsgrunn, Sluiskil) and any guided utilization improvements.
  • Quarterly results and management commentary on merchant exposure and forward sales book.
  • Macro energy moves: natural gas and hydrogen price trends that affect feedstock economics and regional plant economics.

Trade plan (actionable)

This is a directional long with constrained risk and a time horizon that gives commodity markets room to re-price.

Action Price Horizon
Entry $29.01 long term (180 trading days)
Stop loss $25.50
Target $36.00 Expect price discovery into target as urea/ammonia margins normalize higher and market re-rates multiple.

Why these levels?

  • Entry at $29.01 captures the current trade; momentum indicators (10/20 day SMAs and a positive MACD) support entering without waiting for a pullback.
  • Stop at $25.50 sits below the 50-day SMA (~$25.57) and provides a clear technical invalidation: a break below that level would suggest momentum and the commodity-pricing thesis are not playing out.
  • Target $36 assumes a move back towards previous favorable cyclical multiples (and leaves room above the recent $29.45 high); hitting $36 would reflect a meaningful re-rating and earnings uplift driven by higher urea/ammonia pricing and improved utilization.

Risks and counterarguments

  1. Commodity reversal: Urea and ammonia prices are volatile. A sudden fall in feedstock prices or oversupply could compress margins and leave Yara exposed to weaker earnings. Commodity cycles can reverse quickly and force a re-rating lower.
  2. Operational disruptions: Yara operates large, export-oriented plants; unexpected outages, maintenance overruns, or logistic bottlenecks could materially reduce near-term volumes and offset price gains.
  3. Project execution & capex risks: The company's clean ammonia ambitions are capital intensive. Cost overruns or delays could hurt returns and constrain free cash flow, limiting the upside from higher spot prices.
  4. Macro energy shocks: Natural gas and hydrogen price spikes could paradoxically increase input costs faster than product price pass-through, squeezing margins in the short run.
  5. Geopolitical/regulatory risk: Trade restrictions, export controls or fertilizer subsidy changes in large consuming countries could alter global flows and regional prices in ways that are unfavorable to Yara.

Counterargument: The market already priced in upside. One could argue that the recent run to $29 is a forward-looking priced-in response to better fertilizer economics and that the remaining upside is limited. That is plausible — and if earnings upgrades are already embedded into consensus, the re-rating will be muted. To be clear: this trade is not a nose-bleed buy on froth; I expect the primary driver of return will be higher realized margins from urea/ammonia, not merely multiple expansion.

What would change my mind?

I would exit or flip bearish if any of the following occur: (1) urea and ammonia spot prices fall consistently below pre-announcement levels and stay weak for multiple months; (2) Yara reports a material disruption at a major plant that eliminates a material portion of merchant sales; (3) management pushes out clean ammonia projects and signals significant incremental capex or cash burn without a clear path to returns. Conversely, I would add on any sustained confirmation of rising merchant pricing, better utilization, or clear contracting wins on clean ammonia projects.

Bottom line

Yara is a pragmatic way to play a fertilizer cycle that I expect to be stronger than the market currently assumes. At a $14.78B market cap and a modest multiple, the stock offers asymmetric upside if urea and ammonia stay tight and if Yara executes on operations and project optionality. The trade plan above balances conviction with disciplined risk control: enter at $29.01, stop at $25.50 and target $36.00 over a long term (180 trading days) horizon. Watch the catalysts closely — spot fertilizer prices and plant utilization will tell you if the thesis is unfolding.

Key monitoring checklist: urea/ammonia spot prices, utilization rates at major plants, quarterly margin commentary, and any material updates on clean ammonia project timelines or costs.

Risks

  • Urea/ammonia price reversal that compresses margins and reverses earnings improvements.
  • Unplanned plant outages or maintenance at large export-oriented facilities that reduce merchant volumes.
  • Delays or cost overruns on clean ammonia projects that divert cash and lower returns.
  • Energy input shocks (natural gas/hydrogen) that increase feedstock costs faster than product price pass-through.

More from Trade Ideas

UnitedHealth: A Timely Buy as Operational Fixes Start to Show Apr 5, 2026 Accelerant Holdings: An Underappreciated Insurtech Re-rating Candidate Apr 5, 2026 Broadcom Poised to Re-Accelerate — A Tactical Long as AI Infrastructure Rotates Back In Apr 5, 2026 Zillow Upgrade: Buybacks, AI and a Cleaner Balance Sheet Create a Tactical Long Apr 5, 2026 Crocs: Cash-Heavy, Buybacks Working, and a LEGO-Style Product Flywheel — Time to Buy Apr 5, 2026